Number of pages: 100 | Report Format: PDF | Published date: 14 July, 2022
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
The global e.coli testing market was pegged at US$ 1.6 in 2021 and is expected to witness a CAGR of 7.3% during the forecast period.
Market Fundamentals
Escherichia coli (E. coli) are rod-shaped gram-negative bacteria found in the guts of humans and animals. Some e.coli strains are essential components of a healthy human intestinal system and the vast majority of e.coli strains are usually harmless. Moreover, some strains of e.coli, such as shiga toxin-producing e.coli, can cause serious foodborne illness and are most commonly transmitted through the consumption of undercooked or raw ground meat products, contaminated raw vegetables, raw milk, and sprouts. There are various pathogenic e.coli strains that are classified based on their pathotypes. There are nearly six pathotypes of e.coli that are associated with diarrhea and are known as diarrheagenic e.coli.
The process of detecting and monitoring the presence of foodborne pathogens is referred to as e.coli testing. E.coli infection can cause a variety of illnesses, including food poisoning, pneumonia, and urinary tract infections (UTIs). According to a study published in the journal Emerging Infectious Diseases, Escherichia coli is responsible for 80-85 percent of all urinary tract infections. Cases of E. coli infection are usually confirmed by the presence of bacteria in infected people's stool. Furthermore, the bacterium is found on the skin of animals, most notably sheep, cows, and goats.
[74543]
Market Dynamics
Factors such as an increase in the prevalence of diarrhea and Hemolytic Uremic Syndrome (HUS), as well as an increase in the number of water-borne diseases, which are more prevalent in developing and underdeveloped countries, are the prime driving factors during the forecast period. The global concern for the improvement of quality of life has resulted in the need for timely testing of the food and water that are consumed, as well as the avoidance of ingestion of contaminated products in the future, which is expected to help the industry grow in the coming years. However, the reliability of testing kits will be a major challenge for the escherichia coli testing market during thr forecast period.
Market Ecosystem
The global E.coli Testing Market has been analyzed from three perspectives, Testing Method, End Users, and Region.
E.coli Testing Market by Testing Method
[987543]
Based on the testing method, the e.coli testing market has been segmented into environmental testing method and clinical testing method. The environmental testing method is sub-segmented into membrane filtration, multiple tube fermentation and enzyme substrate method while clinical testing method is also sub-segmented into polymerase chain reaction, enzyme immunoassays and others. Enzyme immunoassay (EIA) kits segment dominated the market during forecast period. However, environment testing method has shown the fastest growth, owing to factors such as the need for less skill and equipment, as well as the ability to test large sample sizes, such as water bodies. Various environmental samples are tested on a regular basis to detect e. coli contamination and to take preventive measures, particularly during epidemics, to halt the spread of infections. As a result, the rapid rise in water and foodborne diseases has increased global demand for e. coli testing. During disease outbreaks, The World Health Organization (WHO) encourages national strategies and initiatives in developing countries to promote the management of diarrhea and its complications, as well as to improve access to safe drinking water and sanitation. Water test kits are useful in rural areas where the regions may lack laboratory equipment for water quality monitoring.
E.coli Testing Market by End User
Based on the end user, the e.coli testing market has been segmented into water and wastewater treatment plants, government agencies, hospitals and clinics, diagnostic laboratories and others (private well owners, farm testing, drinking water suppliers etc) . Diagnostic Laboratories are the fastest growing market segment. They are used to identify e.coli infections. To diagnose the disease caused by the bacterium, a sample of the patient's stool is sent to a laboratory for testing to determine the presence of E.coli infection. To confirm the diagnosis, bacterium cultures are grown and specific toxins produced by E.coli are discovered.
E.coli Testing Market by Region
During the forecast period, North America dominates the e.coli testing market. The major driving factors for this market in the region are hygienic awareness, stringent government regulations, and the presence of all key players. Asia Pacific, on the other hand, is expected to grow rapidly during the forecast period. This is primarily due to improvements in the region's healthcare infrastructure, government regulation to ensure water purity, and the focus of major players in the region.
Competitive Landscape
Some of the prominent players operating in the global e.coli testing market include
Strategic Developments
Report Attribute |
Details |
Market size value in 2021 |
USD 1.6 billion |
Revenue forecast in 2030 |
USD 3.01 billion |
Growth Rate |
CAGR of 7.3% from 2022 to 2030 |
Base year for estimation |
2021 |
Forecast period |
2022-2030 |
Segments covered |
Testing Method, End Users |
Regional scope |
North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
The global e.coli testing market was anticipated to clock US$ 1.6 in 2021
The e.coli testing market is projected to reach US$ 3.01 billion by 2030
The global e.coli testing market is mainly driven by rising prevalence of water-borne diseases as well as the growing global demand for clean potable water
Meridian Bioscience, Inc., Becton, Dickinson and Company, IDEXX Laboratories, Inc., CPI International, Inc., Pro-Lab Diagnostics, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., BioMerieux Inc., Alere Inc, NanoLogix, Inc., among others
The growth rate of e.coli testing market is CAGR of 7.3% between 2022-2030
North America held the largest market share of the global e.coli testing market.
*Insights on financial permanence is subject to availability of information in public domain
Growth+Reports can now be customized as per client’s needs through GRG Health’s primary research and knowledge services capabilities
GRG Health’s unique GrowthMIX approach and robust research methodology helps us deliver unique & meaningful insights to our clients and uncover trends that won’t meet the standard approach